Asuhan Gizi Individual pada Sirosis Hati Dekompensata Sekunder akibat MAFLD dengan Asites Masif dan Hiperglikemia Reaktif

  • Ririn Iryani Universitas Sebelas Maret
  • Wiwik Ekorinawati Instalasi Gizi RSUD Dr. Moewardi Surakarta
  • Indrawati Indrawati RSUD Dr. Moewardi Surakarta
  • Ahmad Fahrudin Instalasi Gizi RSUI Banyubening
  • Fatimah Azzahra Instalasi Gizi RSUI Banyubening
Keywords: sirosis hepatitis, MAFLD, asites, hiperglikemia, asuhan gizi

Abstract

Latar Belakang: Sirosis hepatis dekompensata akibat metabolic dysfunction-associated fatty liver disease (MAFLD) sering disertai malnutrisi, asites, gangguan metabolisme glukosa, dan risiko hepatic sarcopenia yang memerlukan penatalaksanaan gizi komprehensif. Penelitian ini bertujuan mendeskripsikan pelaksanaan asuhan gizi individual pada pasien sirosis hepatis dekompensata Child-Pugh B akibat MAFLD dengan asites permagna dan hiperglikemia reaktif.
Metode: Penelitian ini menggunakan desain studi kasus dengan pendekatan Nutrition Care Process (NCP) yang meliputi asesmen, diagnosis, intervensi, monitoring, dan evaluasi gizi.
Hasil: Pasien mengalami malnutrisi terkait penyakit kronik dengan inflamasi, ditandai oleh %LILA 85,3%, asupan energi-protein tidak adekuat, asites permagna, anemia, hiperglikemia reaktif, dan risiko hepatic sarcopenia. Setelah intervensi, asupan energi meningkat dari 900,2 kkal menjadi 1.149 kkal dan asupan protein dari 37,4 g menjadi 52 g, disertai perbaikan toleransi makan dan kondisi klinis.
Kesimpulan: Asuhan gizi individual berbasis GLIM membantu meningkatkan asupan energi-protein dan mendukung stabilisasi kondisi klinis pasien sirosis hepatis dekompensata akibat MAFLD.

Keywords / Kata kunci
Sirosis hepatis; MAFLD; asites; hiperglikemia; asuhan gizi

References

Bartlett M, et al. Malnutrition assessment in liver cirrhosis. Nutrients. 2025;17(2):1–15.

Bischoff SC, Bernal W, Dasarathy S, et al. ESPEN practical guideline: Clinical nutrition in liver disease. Clin Nutr. 2020;39(12):3533–3562.

Lai JC, Tandon P, Bernal W, et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis. Hepatology. 2021;74(3):1611–1644.

Abenavoli L, Caprio M, Luzza F, et al. Sarcopenia and metabolic dysfunction-associated steatotic liver disease. Livers. 2024;4(4):732–748.

Allen SL, Quinlan JI, Dhaliwal A, et al. Sarcopenia in chronic liver disease: mechanisms and countermeasures. Am J Physiol Gastrointest Liver Physiol. 2021;320(3):G241–G257.

Mohan BP, et al. Diabetes mellitus and liver cirrhosis: Pathophysiological links. World J Hepatol. 2025;17(1):20–35.

Tacke F, et al. EASL–EASD–EASO Clinical Practice Guidelines on metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;80(3):1–45.

American Diabetes Association Professional Practice Committee. Standards of care in diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S1–S350.

Biggins SW, et al. Diagnosis, evaluation, and management of ascites and hepatorenal syndrome. Hepatology. 2021;74(2):1014–1048.

Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition: A consensus report from the global clinical nutrition community. Clin Nutr. 2019;38(1):1–9.

Raymond JL, Morrow K. Krause and Mahan's Food & the Nutrition Care Process. 16th ed. St. Louis (MO): Elsevier; 2021.

He Y, Wang Z, Wu S, et al. Screening and assessment of malnutrition in patients with liver cirrhosis. Front Nutr. 2024;11:1398690.

de Franchis R, et al. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959–974.

Kaplan DE, et al. AASLD practice guidance on portal hypertension and variceal bleeding. Hepatology. 2024;79(1):1–35.

Leoni L, et al. Unlocking the power of late-evening snacks: A narrative review of nutritional strategies in cirrhosis. Nutrients. 2023;15(15):3471.

Pelton M, et al. Role of nutrition in the management of chronic liver disease. Nutrients. 2025.

World Health Organization. Diabetes fact sheet. Geneva: World Health Organization; 2024.

Published
2026-06-30